4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000155
Director sold 3,080 shares at an average $22.14 ($68,204)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1720055578.xml…